(Q52959273)
Statements
Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab (English)
Jan Brandt
Hildrun Haibel
Jaqueline Reddig
Joachim Sieper